Itron: Actual Results Would Provide More Comfort Than Upbeat Words

Itron faces muted sales growth, soft bookings, and a questionable acquisition-driven strategy, leading to a cautious stance despite management's upbeat narrative. First-quarter sales declined 3% to $587 million, with margins under pressure and bookings translating to a weak 0.81x book-to-bill ratio. Recent $850 million acquisitions contribute minimally to revenue, raising concerns about deal multiples and future earnings dilution.